Pivot Bio is a sustainable agriculture company that develops microbial nitrogen fertilizers to replace synthetic nitrogen fertilizer. Their products help corn, wheat and rice farmers improve crop yield and reduce costs by enabling crops to capture and metabolize nitrogen from the air. In FY2023, Pivot Bio reached $100M in revenue for the first time, with products used on over 5 million acres of U.S. farmland. The company is expanding manufacturing and distribution capacity across the Midwest to support continued strong growth.
Co-founders Karsten Temme (former CEO, now Chief Innovation Officer) and Alvin Tamsir have deep expertise in bioengineering and molecular biology from over a decade of research. Their proprietary microbial nitrogen has just 2% of the emissions of synthetic fertilizer and requires 1,000 times less water to produce. By making this technology commercially available at scale, Pivot Bio aims to disrupt the $190 billion global nitrogen fertilizer market.
2011
Founded
250-500
Employees
Series D
Stage
~$2B
Latest Valuation
$400-700M
Total Funding
Jul 19 2021
Last Fundraise
Why is the rating
Open Roles
Top Previous Employers

Bayer

Corteva Agriscience

Monsanto Company

University of California, Berkeley

University of California, Davis